Science that starts with the cause.

Our Approach

Mechanism-first drug discovery

Traditional drug discovery often begins with a known target and works backward to the disease. Solume inverts this process. We start with the disease biology — the precise molecular pathway that initiates and sustains the condition — and design therapies that correct it.

This approach requires deep investment in understanding disease mechanisms before entering the laboratory, but it produces candidates with higher specificity, fewer off-target effects, and the potential for curative rather than palliative outcomes.